Related Experiment Video
Updated: Mar 17, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Disorders of Iron Metabolism and Anemia in Chronic Kidney Disease
Bhupesh Panwar1, Orlando M Gutiérrez2
1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL.
Insights
Disordered iron homeostasis causes anemia in chronic kidney disease (CKD) and treatment resistance. New insights reveal iron and mineral metabolism links, impacting CKD anemia management.
Area of Science:
- Nephrology
- Hematology
- Mineral Metabolism
Background:
- Anemia is a common complication of chronic kidney disease (CKD).
- Dysregulated iron homeostasis is a key factor in CKD anemia development.
- Altered iron metabolism contributes to resistance to erythropoiesis-stimulating agents in CKD.
Purpose of the Study:
- To review the pathophysiology of anemia in CKD related to iron metabolism.
- To explore recent advances in understanding iron regulation and its alterations in CKD.
- To examine the interplay between iron homeostasis and bone and mineral metabolism in CKD.
Main Methods:
- Literature review of recent discoveries in iron biology and CKD.
- Analysis of hormonal regulation of iron trafficking.
- Exploration of emerging evidence on iron-mineral metabolism interactions.
Main Results:
- Dysregulated iron homeostasis is central to CKD anemia.
- Hormonal regulation of iron trafficking is crucial for understanding CKD anemia.
- Interactions between iron and mineral metabolism offer new insights into CKD pathophysiology.
Conclusions:
- Understanding normal iron physiology is essential for managing CKD anemia.
- Altered iron metabolism in CKD is complex and multifactorial.
- The connection between iron and mineral metabolism has significant implications for managing CKD anemia and iron status.
Abstract:
Dysregulated iron homeostasis plays a central role in the development of anemia of chronic kidney disease (CKD) and is a major contributor toward resistance to treatment with erythropoiesis-stimulating agents. Understanding the underlying pathophysiology requires an in-depth understanding of normal iron physiology and regulation. Recent discoveries in the field of iron biology have greatly improved our understanding of the hormonal regulation of iron trafficking in human beings and how its alterations lead to the development of anemia of CKD. In addition, emerging evidence has suggested that iron homeostasis interacts with bone and mineral metabolism on multiple levels, opening up new avenues of investigation into the genesis of disordered iron metabolism in CKD. Building on recent advances in our understanding of normal iron physiology and abnormalities in iron homeostasis in CKD, this review characterizes how anemia related to disordered iron metabolism develops in the setting of CKD. In addition, this review explores our emerging recognition of the connections between iron homeostasis and mineral metabolism and their implications for the management of altered iron status and anemia of CKD.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease I: Introduction
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Chronic Kidney Disease IV: Nursing Management
Acute Kidney Injury IV: Diagnostic Studies and Prevention

